Photocure ASA

Photocure ASA: Share capital increase registered - correction

*Number of shares following registration of share issue is corrected

Oslo, Norway, 15 December 2020: Reference is made to the stock exchange release

by Photocure ASA ("Photocure" or the "Company") published on 3 December 2020

regarding registration of a share capital increase following the exercise of

share options.

The issuance of 90,150 new shares has been registered with the Norwegian

Photocure is NOK 13,358,768 divided into *26,717,536 shares, each with a par

value of NOK 0.50. Each share represents one vote in the Company's general

meeting.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, which makes

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

All trademarks mentioned in this release are protected by law and are registered

trademarks of Photocure ASA.

This information is subject to the disclosure requirements pursuant to sections

5-12 of the Norwegian Securities Trading Act.

AI Terminal